ACHVACHIEVE LIFE SCIENCES, INC.

Nasdaq achievelifesciences.com


$ 4.44 $ 0.07 (1.6 %)    

Thursday, 15-Aug-2024 15:59:27 EDT
QQQ $ 474.24 $ 11.69 (2.53 %)
DIA $ 405.85 $ 5.79 (1.45 %)
SPY $ 553.01 $ 9.32 (1.71 %)
TLT $ 97.07 $ -0.79 (-0.81 %)
GLD $ 226.93 $ 0.71 (0.31 %)
$ 4.45
$ 4.44
$ 4.43 x 200
-- x --
$ 4.43 - $ 4.51
$ 3.03 - $ 5.98
77,571
na
152.72M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-16-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-10-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-11-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-13-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-14-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 03-01-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 07-31-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-12-2016 03-31-2016 10-Q
35 03-09-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-26-2015 12-31-2014 10-K
40 10-30-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 oppenheimer-reiterates-outperform-on-achieve-life-sciences-maintains-11-price-target

Oppenheimer analyst Francois Brisebois reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Outperform and maintains $11 pr...

 achieve-life-sciences-q2-2024-gaap-eps-025-misses-023-estimate

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate ...

 oppenheimer-maintains-outperform-on-achieve-life-sciences-lowers-price-target-to-11

Oppenheimer analyst Francois Brisebois maintains Achieve Life Sciences (NASDAQ:ACHV) with a Outperform and lowers the price ...

 achieve-life-sciences-q1-2024-gaap-eps-026-misses-024-estimate

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate ...

 achieve-life-sciences-announces-publication-of-cytisinicline-vaping-cessation-trial-results-in-jama-internal-medicine-phase-2-orca-v1-trial-showed-treatment-with-cytisinicline-more-than-doubled-odds-of-quitting-e-cigarettes-compared-with-placebo

Phase 2 ORCA-V1 trial showed treatment with cytisinicline more than doubled odds of quitting e-cigarettes compared with placebo...

 achieve-life-sciences-files-prospectus-related-to-offer--sale-from-time-to-time-of-up-to-131m-shares-of-common-stock-by-selling-stockholders

- SEC Filing

 jonestrading-initiates-coverage-on-achieve-life-sciences-with-buy-rating-announces-price-target-of-20

JonesTrading analyst Justin Walsh initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces ...

 oppenheimer-reiterates-outperform-on-achieve-life-sciences-maintains-18-price-target

Oppenheimer analyst Francois Brisebois reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Outperform and maintains $18 pr...

 achieve-life-sciences-q4-eps-026-beats-031-estimate

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

Core News & Articles

-SEC Filing

 lake-street-maintains-buy-on-achieve-life-sciences-lowers-price-target-to-11

Lake Street analyst Thomas Flaten maintains Achieve Life Sciences (NASDAQ:ACHV) with a Buy and lowers the price target from ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION